TCGA data showed that among patients with rectal cancer, the LGMNHigh group had significantly shorter survival than the LGMNLow group (P < 0.05), further supporting the associations between high legumain expression, tumor progression, and poor prognosis. The gene discussed is LGMN; the disease is neoplasm.